

Dr. Edward Wright - VPU Pseudotyped viruses for emerging and zoonotic infections
Dr. Edward Wright - Viral Pseudotype Unit speaks at ISNTD Bites 2013 on Pseudotyped viruses for emerging and zoonotic infections and discuss


Mark Carnegie-Brown (Oxitec): Advanced genetics & molecular biology for Aedes control
At the annual ISNTD Bites conference on vector-borne diseases and vector control, Mark Carnegie-Brown, CEO at Oxitec, speaks about the impac


Paul Ready (Natural History Museum): Integrated control of leishmaniasis in Brazil
At the annual ISNTD Bites conference on vector-borne diseases and vector control, Paul Ready, from the Natural History Museum London and the


Workshop: Vector Borne Disease Toolkit with Dr Richard Allan (MENTOR Initiative)
Dr. Richard Allan CEO of the MENTOR Initiative conducts an interactive workshop at our July 2017 annual ISNTD Bites conference. Disease cont


Pr. David Molyneux (Liverpool School of Tropical Medicine): NTDs & Mental Health
Pr. Molyneux speaks at ISNTD Coinfections & Comorbidities (April 2016) about "NTDs & mental health - recognizing the true burde


Theresa Maier (Merck): Gene editing platform for snail control & schistosomiasis
At the annual ISNTD Bites 2017 conference on vector-borne diseases and vector control, Theresa Maier, from the University of Cambridge, spea


Dr. Benny Baeten (J&J Global Health): Solutions for Soil-Transmitted Helminths & Onchocercia
At ISNTD d³ 2017, Dr. Benny Baeten, Compound Development Team Leader Anthelmintics at Janssen Pharmaceutica (a J&J Global Health company


ISNTD interview: Dr. Maria Clara Echeverry Guitan (Univ. de Colombia)
Dr. Echeverry Guitan speaks at ISNTD d³ 2016 with the ISNTD about current research on leishmaniasis & drug discovery at the University o


Panel discussion: Current gaps & research priorities for NTD drug discovery May 2017
Panel discussion at ISNTD d³ 2017, chaired by Mr. Duc H. Le, Editor in Chief at EBio Medicine.
Panelists are:
• Dr. Benny Baeten (J&J


Dr. Judith Kallenberg (GAVI)
Judith Kallenberg, Head of Policy at GAVI, speaks to the ISNTD about GAVI's role in driving access to vaccines globally as well as lesso